Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications (Q22242884)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013215%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

2

Jenny Myers

Jenny

Myers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013215%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

5

Emma J Crosbie

Emma J

Crosbie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013215%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Susie Nicholas

3

Susie

Nicholas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013215%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Adam H Balen

series ordinal

4

author given names

Adam H

author last names

Balen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013215%20AND%20SRC:MED&resulttype=core&format=json

Human Reproduction Update

11 June 2020

language of work or name

English

0 references

publication date

10 July 2014

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013215%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013215%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013215%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

853-868

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013215%20AND%20SRC:MED&resulttype=core&format=json

A systematic review on animal models of maternal high fat feeding and offspring glycaemic control.

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin reduces endogenous reactive oxygen species and associated DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Insulin resistance in the control of body fat distribution: a new hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin directly inhibits androgen production in human thecal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Ovulation induction in the management of anovulatory polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Impact of obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Should obese women with polycystic ovary syndrome receive treatment for infertility?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Human placental lactogen: studies of its acute metabolic effects and disposition in normal man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin and the risk of endometrial cancer: a case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Use of metformin and the risk of ovarian cancer: a case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Effect of metformin taken in the 'fresh' in vitro fertilization/intracytoplasmic sperm injection cycle upon subsequent frozen embryo replacement in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

The effect of metformin on apoptosis in a breast cancer presurgical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Disordered follicle development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin in management of pregnant insulin-independent diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Consensus on infertility treatment related to polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

A 10-year retrospective analysis of pregnancy outcome in pregestational Type 2 diabetes: comparison of insulin and oral glucose-lowering agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Effects of metformin on mammalian target of rapamycin in a mouse model of endometrial hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin and reduced risk of cancer in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Diabetes mellitus and risk of endometrial cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin for gestational diabetes in routine clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Contraindications to use of metformin. Age and creatinine clearance need to be taken into consideration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

A risk-benefit assessment of metformin in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: a prospective, randomized, double-blind, multi-centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin intake is associated with better survival in ovarian cancer: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin and lactic acidosis in diabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Insulin resistance: definition and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Diabetes mellitus and ovarian cancer risk: a systematic review and meta-analysis of observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Diabetes and endometrial cancer: effect modification by body weight, physical activity and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Ovarian hyperstimulation syndrome: pathophysiology and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Lifestyle interventions for overweight and obese pregnant women to improve pregnancy outcome: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Insulin and insulin-like growth factor signalling in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin versus insulin for the treatment of gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Monocyte chemoattractant protein 1 in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin therapy and clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin attenuates blood lipid peroxidation and potentiates antioxidant defense in high fructose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Should patients with polycystic ovary syndrome be treated with metformin? Benefits of insulin sensitizing drugs in polycystic ovary syndrome--beyond ovulation induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

The use of metformin for women with PCOS undergoing IVF treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Pregestational body mass index is related to neonatal abdominal circumference at birth--a Danish population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Comparison of metformin and insulin in the treatment of gestational diabetes: a retrospective, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

The pathophysiology of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin Versus Placebo from First Trimester to Delivery in Polycystic Ovary Syndrome: A Randomized, Controlled Multicenter Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Insulin promotes proliferation, survival, and invasion in endometrial carcinoma by activating the MEK/ERK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Maternal obesity up-regulates inflammatory signaling pathways and enhances cytokine expression in the mid-gestation sheep placenta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

7 January 2021

Introduction of metformin for gestational diabetes mellitus in clinical practice: Has it had an impact?

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

7 January 2021

The insulin and insulin-like growth factor receptor family in neoplasia: an update

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

7 January 2021

Obesity and pregnancy: complications and cost

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

7 January 2021

Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

7 January 2021

Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

7 January 2021

An epidemiologic study of the relationship of reproductive experience to cancer of the ovary

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

7 January 2021

Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

7 January 2021

Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

7 January 2021

Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

7 January 2021

Comparison of antiproliferative effects of metformine and progesterone on estrogen-induced endometrial hyperplasia in rats

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU037

7 January 2021

Identifiers

DOI

10.1093/HUMUPD/DMU037

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013215%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017